PH30236A - Implantable biodegradable system for releasing active substance - Google Patents

Implantable biodegradable system for releasing active substance

Info

Publication number
PH30236A
PH30236A PH37650A PH37650A PH30236A PH 30236 A PH30236 A PH 30236A PH 37650 A PH37650 A PH 37650A PH 37650 A PH37650 A PH 37650A PH 30236 A PH30236 A PH 30236A
Authority
PH
Philippines
Prior art keywords
active substance
releasing active
implantable biodegradable
biodegradable system
carrier material
Prior art date
Application number
PH37650A
Inventor
Herbert Stricker
Gunther Entenmann
Otto Kern
Michel Mikhail
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of PH30236A publication Critical patent/PH30236A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

The system consists of a carrier material based on poly-D,L-lactide and of a drug incorporated therein and, where appropriate pharmaceutical auxiliaries. The carrier material contains defined contents of additives in the form of pore formers, up to about 10% by weight of a physiologically acceptable solvent or plasticiser and/or low molecular weight polymers.
PH37650A 1987-10-09 1988-10-07 Implantable biodegradable system for releasing active substance PH30236A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873734223 DE3734223A1 (en) 1987-10-09 1987-10-09 IMPLANTABLE, BIODEGRADABLE ACTIVE SUBSTANCE RELEASE SYSTEM

Publications (1)

Publication Number Publication Date
PH30236A true PH30236A (en) 1997-02-05

Family

ID=6338006

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37650A PH30236A (en) 1987-10-09 1988-10-07 Implantable biodegradable system for releasing active substance

Country Status (17)

Country Link
EP (1) EP0311065B1 (en)
JP (1) JP2763303B2 (en)
KR (1) KR970006082B1 (en)
AT (1) ATE101035T1 (en)
AU (1) AU609194B2 (en)
CA (1) CA1333770C (en)
DE (2) DE3734223A1 (en)
DK (1) DK175252B1 (en)
ES (1) ES2061589T3 (en)
FI (1) FI100302B (en)
IE (1) IE62505B1 (en)
IL (1) IL87973A (en)
NO (1) NO176304C (en)
NZ (1) NZ226514A (en)
PH (1) PH30236A (en)
PT (1) PT88703B (en)
ZA (1) ZA887535B (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US5252642A (en) * 1989-03-01 1993-10-12 Biopak Technology, Ltd. Degradable impact modified polyactic acid
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US5216050A (en) * 1988-08-08 1993-06-01 Biopak Technology, Ltd. Blends of polyactic acid
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
DK0476045T3 (en) * 1989-06-05 1996-09-16 Massachusetts Inst Technology Biodegradable polymers for drug delivery into bones
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (en) * 1989-07-28 1992-01-15 Debiopharm Sa
CA2069644A1 (en) * 1990-01-30 1991-07-31 Jan Feijen Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
EP0447719B1 (en) * 1990-03-05 1993-11-03 Minnesota Mining And Manufacturing Company Device for extended delivery of pharmacologically active agents to the ear
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
EP0972089B1 (en) * 1997-04-04 2004-12-08 Alcan International Limited Aluminum alloy composition and method of manufacture
AR012448A1 (en) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech COMPOSITION IN THE FORM OF MICROCAPSULES OR IMPLANTS COMPRISING A BIODEGRADABLE CONTAINER, POLYMER OR CO-POLYMER, OR A MIXTURE OF SUCH EXCIPIENTS, AND AN ACTIVE SUBSTANCE OR MIXTURE OF ACTIVE SUBSTANCES, PROCEDURE FOR THE PREPARATION OF A SUBSTANCE IN A SUBSTANCE
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
DE19908753C2 (en) * 1999-02-20 2003-10-02 Jenapharm Gmbh Biodegradable, injectable oligomer-polymer composition
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6702849B1 (en) 1999-12-13 2004-03-09 Advanced Cardiovascular Systems, Inc. Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
DE60132525T2 (en) 2000-03-22 2009-01-29 Dainippon Ink And Chemicals, Inc. PEDESTALIZED MODIFYERS AND POLYESTER COMPOSITION CONTAINING THOSE MODIFIERS
EP3167872B1 (en) * 2000-07-05 2020-10-14 Allergan, Inc. Methods for treating inflammation-mediated conditions of the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
CN100548271C (en) 2004-01-20 2009-10-14 阿勒根公司 Composition for topical treatment of the eye, preferably comprising triamcinolone acetonide and hyaluronic acid
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8512738B2 (en) 2004-04-30 2013-08-20 Allergan, Inc. Biodegradable intravitreal tyrosine kinase implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
PT2010184E (en) 2006-04-06 2013-04-03 Nupathe Inc Implants for the treatment of dopamine associated states
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
EP3421030A1 (en) 2009-11-09 2019-01-02 Allergan, Inc. Compositions and methods for stimulating hair growth
JP4779169B1 (en) * 2010-10-27 2011-09-28 Ｎｅｃインフロンティア株式会社 Button lighting structure, electronic equipment
CA2901280A1 (en) 2013-02-15 2014-08-21 Allergan, Inc. Sustained drug delivery implant
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
JP2020536955A (en) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド Implantable depot for controlled release of therapeutic agent
EP3737433A1 (en) 2018-01-08 2020-11-18 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
WO2019221853A1 (en) 2018-05-12 2019-11-21 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
EP3843710A1 (en) 2018-08-28 2021-07-07 Foundry Therapeutics, Inc. Polymer implants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (en) * 1955-12-22
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
DE3218150C2 (en) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Active substance-containing body for long-term release and process for its production
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3710175A1 (en) * 1987-02-12 1988-08-25 Hoechst Ag MULTI-PIECE IMPLANTABLE MEDICINE PREPARATION WITH LONG-TERM EFFECT

Also Published As

Publication number Publication date
DE3887616D1 (en) 1994-03-17
NO884474D0 (en) 1988-10-07
IL87973A0 (en) 1989-03-31
FI100302B (en) 1997-11-14
NO176304B (en) 1994-12-05
FI884604L (en) 1989-04-10
ES2061589T3 (en) 1994-12-16
NO176304C (en) 1995-03-22
IE62505B1 (en) 1995-02-08
AU609194B2 (en) 1991-04-26
ATE101035T1 (en) 1994-02-15
DK561588D0 (en) 1988-10-07
NZ226514A (en) 1990-02-26
DK561588A (en) 1989-04-10
FI884604A0 (en) 1988-10-07
DK175252B1 (en) 2004-07-19
EP0311065B1 (en) 1994-02-02
CA1333770C (en) 1995-01-03
AU2352288A (en) 1989-04-13
KR970006082B1 (en) 1997-04-23
PT88703B (en) 1992-12-31
KR890006222A (en) 1989-06-12
ZA887535B (en) 1990-06-27
NO884474L (en) 1989-04-10
JP2763303B2 (en) 1998-06-11
IE883040L (en) 1989-04-09
DE3734223A1 (en) 1989-04-20
IL87973A (en) 1992-08-18
JPH02117A (en) 1990-01-05
EP0311065A1 (en) 1989-04-12
PT88703A (en) 1988-11-01

Similar Documents

Publication Publication Date Title
ZA887535B (en) Implantable,biodegradable system for releasing active substance
NZ221390A (en) Biodegradable implant containing estradiol and poly(lactide-co-glycolide) polymer: method of administration and preparation
DE69434963D1 (en) SELECTIVE TO THE LIVER ACTIVE PHARMACEUTICALLY ACTIVE SUBSTANCE
DE69019817D1 (en) Carrier material for drug administration.
DE3850823D1 (en) Drug release system and method of manufacture.
NZ221484A (en) Starburst polymer conjugates as carriers for agricultural, pharmaceutical and other materials
NZ216082A (en) Prolonged-release microparticles
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
EP0211601A3 (en) Stabilization of growth promoting hormones
CA2024505A1 (en) Dosage form for delivering soluble or insoluble drugs
DK305087A (en) BUPRENORPHIC CONTAINED PHARMACEUTICAL SUPPLY
ATE94764T1 (en) NASAL APPLICABLE MEDICATION, PROCESS FOR ITS PRODUCTION AND ITS USE.
EP0380989A3 (en) Plaster for transdermal administration
IL85144A (en) Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation
GR1000266B (en) Preparation method of a composition based on a polyester for the controlled emission of pharmaceutical substances
TW221692B (en)
FR2605223B1 (en) STABLE THERAPEUTIC COMPOSITIONS BASED ON HYDROPHOBIC VEGETABLE OIL AND PROCESS FOR PREPARING THE SAME
IL93721A0 (en) Mixed micelles compositions and their use as carriers for the parenteral application of the drugs
Laczay More important drug side-effects and interactions in the veterinary medicine. I. Antibacterial drugs. Review article.